Le Lézard
Classified in: Health
Subjects: AWD, LEG

The Inner Circle Acknowledges, Barry I. Gold Pinnacle Lifetime Member


OAKLAND, N.J., Jan. 2, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Barry I. Gold, is acknowledged as a Pinnacle Lifetime Member for his contributions as a Retired Pharmacology and Author.    

Barry I. Gold, a retired pharmacologist and accomplished author, has dedicated his career to addressing critical issues in the field of chemical pharmacology and advocating for addiction awareness and effective treatments. His expertise and advocacy have made hi

With a background in chemical pharmacology, Barry I. Gold has contributed significantly to the field through his published works and research. His passion for addressing addiction issues has driven him to write a thought-provoking book titled "We're Overdosed," which provides a comprehensive exploration of the history of opioids and the urgent need for effective addiction treatment.

One of Barry's primary advocacy focuses is the importance of addressing addiction through federal legislation. He emphasizes the need for comprehensive measures to prevent the illicit drug trade and ensure individuals have access to evidence-based addiction treatments. His work underscores the critical role that federal legislation plays in curbing addiction and saving lives.

As a retired pharmacologist and accomplished author, Barry I. Gold's contributions extend beyond his professional expertise. He is an active member of the American Society for Pharmacology and Experimental Therapeutics (ASPET), highlighting his dedication to staying connected with the latest advancements in pharmacology and research.

While Barry's professional achievements are significant, he also values the support and love of his children, expressing his gratitude for their unwavering encouragement throughout his journey.

Barry's academic journey includes a Bachelor of Science (B.S.) in Zoology from the University of Cincinnati, a Ph.D. in Pharmacology from Boston University, and a postdoctoral fellowship at Yale University School of Medicine.

Beyond his professional pursuits, Barry enjoys spending time with his family and pursuing his passion for writing. His favorite vacation place is North Carolina, where he finds inspiration and relaxation.

Although he is retired, Barry I. Gold's commitment to addressing addiction and advocating for evidence-based treatments remains steadfast. He believes in the importance of being prepared to pivot if one makes an error in their career choice, emphasizing the need for adaptability and a commitment to making a positive impact.

Barry's career accomplishments are highlighted by his books, and he is currently working on a new project titled "Boomer Dad," reflecting his continued dedication to sharing insights and knowledge with the world.

Barry I. Gold's scientific perspective and advocacy for addiction awareness serve as a source of inspiration for the medical community and individuals striving to make a difference in the field of pharmacology and addiction treatment.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE The Inner Circle


These press releases may also interest you

at 10:11
AvaSure, a market leader in acute virtual care, and Equum Medical, a leader in telehealth-enabled clinical services, will showcase a proven virtual care model that alleviates clinician shortages and is delivering value to healthcare ecosystems at the...

at 10:10
Integrity Orthopaedics, Inc., a company pioneering next generation solutions for soft tissue repair, has successfully closed on a Series B financing of $20.6 million. The financing was co-led by Piper Sandler Merchant Banking and an undisclosed...

at 10:09
QBE North America today announced the launch of its Healthcare Liability practice, a suite of coverages designed to meet the unique needs of healthcare organizations. The practice, which consists of a dedicated team and core products, is part of...

at 10:05
Surf Bio, Inc., a biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6 million grant from the Bill & Melinda Gates Foundation. The grant will provide funding to evaluate the use of the company's lead...

at 10:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, today announced the publication of preclinical data...

at 10:04
GroundGame.Health, a proven social impact solution that fulfills unmet social and care needs for people everywhere, has merged with SameSky Health, a cultural experience company that builds trust and deepens engagement with members. The combined...



News published on and distributed by: